Latest News and Press Releases
Want to stay updated on the latest news?
-
CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024
-
CytoSorbents to Participate in the Piper Sandler 36th Annual Healthcare Conference. Management holding one-on-one meetings with investors
-
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Peripheral Arterial...
-
FDA Accepts DrugSorb-ATR De Novo Application To Reduce CABG-Related Bleeding Severity Due To Brilinta, Starting Substantive Review, 2025 Decision Expected
-
CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
-
CytoSorbents to Report Q2 2024 Financial and Operating Results
-
CytoSorbents to Host Virtual KOL and Analyst-Investor Day on May 6, 2024 to review U.S. and Canada STAR-T Pivotal Trial Topline Results
-
XARELTO Market Size, Forecast, and Market Insight to 2032, with Focus on the United States and Japan
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "XARELTO Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
-
CytoSorbents Provides Update on STAR-T Trial and Final Independent DSMB Recommendation
-
CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress